Pfizer Inc. buy FXX
Start price
12.12.20
/
50%
€35.01
Target price
12.12.21
-
Performance (%)
-14.23%
End price
24.03.21
€30.03
Summary
This prediction ended on 24.03.21 with a price of €30.03. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.23%. A total of €0.32 was paid as dividends for this prediction. FXX has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pfizer Inc. | 0.308% | 0.308% | -33.633% | -24.606% |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
According to FXX what are the pros and cons of Pfizer Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
ROE higher than 10% per year
Good culture
Growths faster than the competition
Top 10 in its market
Known brand
Future proof or reliable business model
Good rating
Standard Investments for future growth
Capable Management
Leading role in innovation
Some uniques
Cons
Significant cyclical dependencies
negative Cash Flow expected
Risky balance sheet
Dependend from some customers or products
Sustainability is little important
Higher risks for its business
Increased challenges to pay loans and raise capital
Comments by FXX for this prediction
In the thread Pfizer Inc. diskutieren
Buy Pfizer Inc.